Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (1574)	11/4/1998 12:30:00 AM
From: Steve Harmon	Read Replies (2) \| Respond to of 2742

John de C, Agreed. Buying back shares in any fashion on the open market would do wonders for shareholder value at these distressed levels. Cistron now has 2 investment bankers to provide stock support, the world's largest vaccine company as a partner, and $13 million debt free dollars. Cistron's current market value is $5 million dollars...Amazing! Steve

To: Dr. John M. de Castro who wrote (1574)	11/4/1998 9:46:00 AM
From: Walter Morton	Respond to of 2742

That sounds like a very good compromise when you compare it to a 4 million buy back. However, I think the news release stated that the PMC purchased (past tense)not will purchase ... Does that mean our stock value has been diluted by 5%? Is that why the stock price did not go up much on anticipation of the deal?